Fundamental analysis

DGAP-News: Ekosem-Agrar AG with positive operating development in the first half of 2021

Retrieved on: 
Friday, July 30, 2021

Despite the weaker ruble, the company achieved a 12% increase in sales revenues to around EUR 235 million (previous year: EUR 209.0 million).

Key Points: 
  • Despite the weaker ruble, the company achieved a 12% increase in sales revenues to around EUR 235 million (previous year: EUR 209.0 million).
  • At EUR 130 million, earnings before interest, taxes, depreciation and amortization (EBITDA) were just on a par with the prior-year period (EUR 132.8 million).
  • As of 30 June 2021, a production output of more than 1,026,000 tons was achieved in the preceding twelve months.
  • Ekosem-Agrar AG, Walldorf, is the German holding company of the EkoNiva Group, one of the largest Russian agricultural companies.

DGAP-News: RIB Software SE: The RIB Group announces its figures for the first half of 2021: Stable revenue growth (+8.6%) with strong operating margin (29.5%)

Retrieved on: 
Friday, July 30, 2021

RIB Software SE: The RIB Group announces its figures for the first half of 2021: Stable revenue growth (+8.6%) with strong operating margin (29.5%)

Key Points: 
  • RIB Software SE: The RIB Group announces its figures for the first half of 2021: Stable revenue growth (+8.6%) with strong operating margin (29.5%)
    The issuer is solely responsible for the content of this announcement.
  • Group revenues, adjusted for the e-commerce revenues still included in the previous year, increased by 8.6% to 138.7 million (previous year: 127.7 million).
  • Software revenues grew by 0.8% to 102.8 million (previous year: 102.0 million).
  • EBITDA fell by 16.7% year-on-year to 38.9 million (previous year: 46.7 million), resulting in an EBITDA margin of 28.0% (previous year: 36.6%).

IRADIMED CORPORATION Announces Second Quarter 2021 Financial Results

Retrieved on: 
Friday, July 30, 2021

For the second quarter 2021, domestic sales were 82.0 percent of total revenue, compared to 68.3 percent for the second quarter 2020.

Key Points: 
  • For the second quarter 2021, domestic sales were 82.0 percent of total revenue, compared to 68.3 percent for the second quarter 2020.
  • Gross profit margin was 74.7 percent for the second quarter 2021, compared to 72.6 percent for the second quarter 2020.
  • For the second quarter ended June 30, 2021, free cash flow was $3.5 million, compared to $0.7 million for the second quarter 2020.
  • All of our non-GAAP financial measures are important tools for financial and operational decision making and for evaluating our on-going core operating results.

Bioventus Inc. Reports Preliminary Second Quarter Net Sales; Updates Full-Year 2021 Net Sales Guidance

Retrieved on: 
Thursday, July 29, 2021

Updated Full-Year 2021 Net Sales Guidance:

Key Points: 
  • Updated Full-Year 2021 Net Sales Guidance:
    For the twelve months ending December 31, 2021, the Company now expects net sales of $405 million to $415 million, up approximately 26% to 29% year-over-year.
  • The full-year 2021 net sales guidance range comprises:
    Net sales from legacy Bioventus Inc. of $372.5 million to $380.5 million, representing organic revenue growth* in the range of approximately 16% to 18% year-over-year, and,
    Net sales from the acquisition of Bioness Inc., of approximately $32.5 million to $34.5 million.
  • The Company will update its full year 2021 guidance for GAAP and non-GAAP net income and adjusted EBITDA as part of its earnings press release on August 10, 2021.
  • Selected preliminary financial results for the three months ended July 3, 2021
    This press release presents preliminary results, for the periods presented, of Bioventus Inc., including Bioventus LLC, the predecessor of Bioventus Inc. for financial reporting purposes.

Global Lyophilized Injectable Market (2021 to 2031) - Industry Analysis, Size, Share, Growth, Trends and Forecasts - ResearchAndMarkets.com

Retrieved on: 
Friday, July 30, 2021

The "Lyophilized Injectable Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2031" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Lyophilized Injectable Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2031" report has been added to ResearchAndMarkets.com's offering.
  • The report also provides the compound annual growth rate (CAGR %) of the global lyophilized injectable market from 2021 to 2031.
  • Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global lyophilized injectable market.
  • These serve as valuable tools for existing market players as well as entities interested in participating in the global lyophilized injectable market.

Fluidra Continues Its Record Performance in the First Half, Increasing Net Profit to 174.2 Million Euros, and Upgrading Its Guidance

Retrieved on: 
Friday, July 30, 2021
Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20210730005166/en/
    The company ended the first six months of the year with 1,187 million euros in sales, up 54% compared to the same period in 2020.
  • Net Profit reached 174 million euros, tripling the profits recorded in the first half of 2020.
  • EBITDA was up 95% to 330 million euros and Cash Net Profit, a key proxy for Fluidra that excludes non-cash items and non-recurring expenses, was up 157% to 216 million euros.
  • The Rest of the World also saw a rise of 30%, helped by the positive performance of Residential Pool activity in Australia.

Universal Logistics Holdings Reports Second Quarter 2021 Financial Results; Declares Dividend; Approves Stock Repurchase Plan

Retrieved on: 
Thursday, July 29, 2021

In the second quarter 2021, Universal's operating income increased $20.5 million to $31.3 million compared to operating income of $10.8 million in the second quarter one year earlier.

Key Points: 
  • In the second quarter 2021, Universal's operating income increased $20.5 million to $31.3 million compared to operating income of $10.8 million in the second quarter one year earlier.
  • EBITDA, a non-GAAP measure, increased $23.6 million during the second quarter 2021 to $53.7 million, compared to $30.2 million one year earlier.
  • Second Quarter 2021 Operating Revenues: $106.6 million, 28.6% increase
    Second Quarter 2021 Operating Income: $6.2 million, 5.8% operating margin
    Operating revenues in the intermodal segment increased $23.7 million to $106.6 million in the second quarter 2021, compared to $82.9 million for the same period last year.
  • Second Quarter 2021 Operating Revenues: $60.4 million, 51.3% increase
    Second Quarter 2021 Operating Income: $2.4 million, 4.0% operating margin
    Second quarter 2021 operating revenues in the company-managed brokerage segment increased 51.3% to $60.4 million compared to $39.9 million for the same period last year.

Ekinops H1 2021 financial statements:11% revenue growth and 43% EBITDA increase in H1 2021: record EBITDA margin of 18.4% Annual EBITDA margin target raised

Retrieved on: 
Thursday, July 29, 2021

In geographic terms, business was dynamic in North America and EMEA (Europe, Middle East and Africa excluding France) during the period.

Key Points: 
  • In geographic terms, business was dynamic in North America and EMEA (Europe, Middle East and Africa excluding France) during the period.
  • Growth in North America was 15% in the first half of the year, rising to 25% in US dollars.
  • Over the first half of 2021, the gross margin stood at 27.8million, up 12% from the same period last year.
  • EBITDA margin set another record, at 18.4% versus 14.3% in H1 2020 and 15.9% for full-year 2020.

Factris Continues to Grow Despite Declining Factoring Trend

Retrieved on: 
Thursday, July 29, 2021

AMSTERDAM, July 29, 2021 /PRNewswire/ -- Fintech company Factris has published their results from the first half of 2021, revealing substantial growth in their factoring services compared to 2020. According to the global financing body FCI report, this growth stands in contrast with the rest of the factoring in the EU, which declined roughly 7% during the pandemic.

Key Points: 
  • This was accompanied by an increase of 58% in the number of invoices financed, capturing a 35% growth YoY.
  • Factris grew despite the downturn thanks to their constant technological advancement.
  • Factris was actively developing proprietary technologies well before the pandemic, such as their own platform designed purely for factoring and an AI-powered risk-assessment system funded by the EU.
  • To continue to foster growth during an uncertain financial atmosphere, Factris recently announced the addition of a new advisory board member, Rob Oudman.

Cenovus Generates $1.8 Billion in Adjusted Funds Flow in Q2 2021

Retrieved on: 
Thursday, July 29, 2021

CALGARY, Alberta, July 29, 2021 (GLOBE NEWSWIRE) -- Cenovus Energy Inc. (TSX: CVE) (NYSE: CVE) continues to demonstrate the strengths of the company’s integrated portfolio in its second quarter results, generating cash from operating activities of $1.4 billion, adjusted funds flow of $1.8 billion and free funds flow of $1.3 billion, supporting a reduction in net debt of nearly $1 billion since March 31, 2021. Total production of nearly 770,000 barrels of oil equivalent per day (BOE/d) despite planned turnarounds at several assets, and strong realized commodity prices in the upstream business along with continued recovery of demand for U.S. downstream products drove Cenovus’s strong financial performance, which the company expects will continue through the rest of the year.

Key Points: 
  • 2 Adjusted funds flow, free funds flow and net debt are non-GAAP measures.
  • Adjusted funds flow of $1.8 billion included the impact of integration costs incurred in the quarter.
  • Free funds flow of $1.3 billion included capital investment in the quarter of $534 million.
  • See the Guidance document for more detail, including royalties, cash taxes and adjusted funds flow sensitivities, at cenovus.com .